Optimizing Long-Acting Injectable Administration for Patients Living With Schizophrenia

This educational resource was sponsored by Johnson & Johnson.

In this educational resource, experts from a pharmacy and hospital provide an overview of their respective long-acting injectable antipsychotic programs, which are designed to help improve access and adherence to medications for people living with a severe and persistent mental illness like schizophrenia.